MERCK Kommanditgesellschaft auf Aktien
MKGAF · OTC
Bulios Fair Price
$98.96
37.6% downside
Current Price
$158.7
According to Bulios Fair Price, MKGAF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
MERCK Kommanditgesellschaft is a German multinational pharmaceutical and chemical company headquartered in Darmstadt, founded in 1668. It is one of the oldest pharmaceutical and chemical companies in the world, operating in the fields of biotechnology, pharmaceuticals, and scientific and laboratory technologies. MERCK specializes in the development and manufacture of drugs, chemical compounds, and materials for scientific research. Its key areas of focus include immunotherapy, oncology, neurology, and reproductive health. MERCK is known for its innovation in scientific progress and the development of new therapeutic methods, with a strong global presence in over 70 countries.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Kai Beckmann
Employees
62,461
Headquarters
Darmstadt
Upcoming events
Earnings
Upcoming earnings report